Sinopharm Group Co. Ltd. Announces Board Composition Update

Bulletin Express

Nov 06

Sinopharm Group Co. Ltd. released an announcement outlining its Board composition as of 6 November 2025 in Shanghai, the PRC. The Board includes Non-Executive Directors chaired by Zhao Bingxiang, along with Chen Qiyu, Zu Jing, Xing Yonggang, Chen Yuqing, Wen Deyong, and Feng Rongli. The Executive Director is President Lian Wanyong. The Independent Non-Executive Directors are Li Peiyu, Wu Tak Lung, Yu Weifeng, Shi Shenghao, and Chen Weiru.

The announcement specifies the formation of five Board committees: Audit, Remuneration, Nomination, Strategy and Investment, and Legal and Compliance and Environmental, Social and Governance. Each Board member serves in their respective roles, with some acting as chairpersons and others as committee members, reflecting a structured governance framework. The updated arrangement aims to ensure strategic decision-making, compliance, and effective oversight within the organization.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1183076040"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183076040\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183076040?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-06 16:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183076040","market":"hk","top_or_hot":-1,"title":"Sinopharm Group Co. Ltd. Announces Board Composition Update","media":"Bulletin Express","content":"<p>Sinopharm Group Co. Ltd. released an announcement outlining its Board composition as of 6 November 2025 in Shanghai, the PRC. The Board includes Non-Executive Directors chaired by Zhao Bingxiang, along with Chen Qiyu, Zu Jing, Xing Yonggang, Chen Yuqing, Wen Deyong, and Feng Rongli. The Executive Director is President Lian Wanyong. The Independent Non-Executive Directors are Li Peiyu, Wu Tak Lung, Yu Weifeng, Shi Shenghao, and Chen Weiru.</p>\n<p>The announcement specifies the formation of five Board committees: Audit, Remuneration, Nomination, Strategy and Investment, and Legal and Compliance and Environmental, Social and Governance. Each Board member serves in their respective roles, with some acting as chairpersons and others as committee members, reflecting a structured governance framework. The updated arrangement aims to ensure strategic decision-making, compliance, and effective oversight within the organization.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinopharm Group Co. Ltd. Announces Board Composition Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinopharm Group Co. Ltd. Announces Board Composition Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-06 16:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sinopharm Group Co. Ltd. released an announcement outlining its Board composition as of 6 November 2025 in Shanghai, the PRC. The Board includes Non-Executive Directors chaired by Zhao Bingxiang, along with Chen Qiyu, Zu Jing, Xing Yonggang, Chen Yuqing, Wen Deyong, and Feng Rongli. The Executive Director is President Lian Wanyong. The Independent Non-Executive Directors are Li Peiyu, Wu Tak Lung, Yu Weifeng, Shi Shenghao, and Chen Weiru.</p>\n<p>The announcement specifies the formation of five Board committees: Audit, Remuneration, Nomination, Strategy and Investment, and Legal and Compliance and Environmental, Social and Governance. Each Board member serves in their respective roles, with some acting as chairpersons and others as committee members, reflecting a structured governance framework. The updated arrangement aims to ensure strategic decision-making, compliance, and effective oversight within the organization.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01099","symbol_name":"国药控股","start_time":0,"source_url":"","article_id":"1183076040","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183076040","pubTimestamp":1762418518,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sinopharm Group Co. Ltd. released an announcement outlining its Board composition as of 6 November 2025 in Shanghai, the PRC. The Board includes Non-Executive Directors chaired by Zhao Bingxiang,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01099":"国药控股"},"translate_title":"国药集团股份有限公司宣布董事会组成更新","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"Sinopharm Group Co. Ltd. released an announcement outlining its Board composition as of 6 November 2025 in Shanghai, the PRC. The Board includes Non-Executive Directors chaired by Zhao Bingxiang, along with Chen Qiyu, Zu Jing, Xing Yonggang, Chen Yuqing, Wen Deyong, and Feng Rongli. The Executive Director is President Lian Wanyong. The Independent Non-Executive Directors are Li Peiyu, Wu Tak Lung, Yu Weifeng, Shi Shenghao, and Chen Weiru.\nThe announcement specifies the formation of five Board committees: Audit, Remuneration, Nomination, Strategy and Investment, and Legal and Compliance and Environmental, Social and Governance. Each Board member serves in their respective roles, with some acting as chairpersons and others as committee members, reflecting a structured governance framework. The updated arrangement aims to ensure strategic decision-making, compliance, and effective oversight within the organization.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}